Skip to content
Business Company News, Medical Health Aged Care

CIMIC’s Leighton Asia wins major hospital expansion project in Hong Kong

CIMIC Group 2 mins read

CIMIC Group company Leighton Asia, in joint venture, has been selected by the Hong Kong Hospital Authority to undertake the A$4.3 billion North District Hospital (NDH) expansion project.

The project, which will generate revenue of up to A$2.4 billion for Leighton Asia, will elevate the health infrastructure in the North District of Hong Kong and provide around 1,500 additional hospital beds.

CIMIC Group Executive Chairman Juan Santamaria said: “Modern healthcare infrastructure is foundational to the well-being of communities. We are proud to bring our experience in delivering health facilities and our ‘hospital-first’ approach to this project, which puts the needs of health workers, patients, and community at the forefront. We look forward to working with the Hong Kong Hospital Authority to deliver this upgrade for Hong Kong’s Northern District.”

Leighton Asia Managing Director Brad Davey said: “Leighton Asia, is proud to be part of the team chosen for the North District Hospital expansion, a project that will set new standards in patient care and medical excellence. Our extensive experience in healthcare construction, combined with our deep understanding of local and international standards, uniquely equips us to deliver this state-of-the-art facility.”

The joint venture between Leighton Asia and China Railway First Group will construct the main works for a new acute block, a 20-storey structure covering a construction floor area of 380,000sq m, a single basement level and a mezzanine floor, and various external and landscaping works.


About us:

CIMIC Group is an engineering-led construction, mining, services and public private partnerships leader working across the lifecycle of assets, infrastructure and resources projects. CIMIC Group comprises our construction businesses CPB Contractors, Leighton Asia and Broad, our mining and mineral processing companies Thiess (joint control) and Sedgman, our services specialist UGL and our development and investment arm Pacific Partnerships – all supported by our in-house engineering consultancy EIC Activities. Our mission is to generate sustainable returns by delivering innovative and competitive solutions for clients and safe, fulfilling careers for our people. With a history since 1899, and around 30,000 people in around 20 countries, we strive to be known for our principles of Integrity, Accountability, Innovation and Delivery, underpinned by Safety.


Contact details:

Ms Fiona Tyndall, Communications T+61 2 9925 6188

Media

More from this category

  • Business Company News, Finance Investment
  • 15/01/2025
  • 11:30
Wednesday 15 January 2025

IFM INVESTORS ANNOUNCES SIGNIFICANT GROWTH INVESTMENT IN SPLEND

IFM Investors is pleased to announce a significant investment in Splend Group Pty Ltd (Splend), an Australian-owned company that is a leading provider of subscription vehicles to rideshare drivers across Australia and the United Kingdom. IFM’s Growth Partners Fund 2 is investing in Splend alongside HESTA (through HESTA’s mandate with IFM) and other co-investors, to acquire a stake of 49% in the company. Founded in 2015, Splend has one of the largest electric vehicle fleets in Australia and is supporting rideshare drivers to adopt lower emission vehicles through its all-inclusive flexible finance and ownership offerings whilst improving their earnings capacity.…

  • Business Company News, Finance Investment
  • 15/01/2025
  • 10:35
ABX Group (ASX: ABX)

ABx Group’s subsidiary, ALCORE, enters into agreement with Rio Tinto Aluminium to establish continuous pilot plant near the Bell Bay aluminium smelter in northern Tasmania.

ABx Group Limited (ASX: ABX) ("ABx" or "the Company") and its 83%-owned subsidiary, ALCORE Limited ("ALCORE"), are pleased to announce that it has entered into a lease agreement with Rio Tinto Aluminium Limited for an industrial facility adjacent to its Bell Bay aluminium smelter in northern Tasmania. ALCORE will establish a pilot plant at the facility to demonstrate its world-first proprietary process to produce industrial chemicals, including hydrogen fluoride, from a waste product created during the aluminium smelting process. In the planned subsequent commercial plant, hydrogen fluoride will be converted to aluminium fluoride, an essential chemical for aluminium smelting that…

  • Contains:
  • Medical Health Aged Care
  • 15/01/2025
  • 10:33
Monash University

The Lancet Diabetes & Endocrinology: Global Commission proposes major overhaul of obesity diagnosis, going beyond BMI to define when obesity is a disease.

A global Commission, published in The Lancet Diabetes & Endocrinology and endorsed by 75 medical organisations around the world [1], presents a novel, nuanced approach to diagnose obesity, based on other measures of excess body fat in addition to body mass index (BMI), and objective signs and symptoms of ill health at the individual level. The proposal is designed to address limitations in the traditional definition and diagnosis of obesity that hinder clinical practice and healthcare policies, resulting in individuals with obesity not receiving the care they need. By providing a medically coherent framework for disease diagnosis, the Commission also…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.